Back to Search
Start Over
A novel acquired EGFR-SEPT14 fusion confers differential drug resistance to EGFR inhibitors in lung adenocarcinoma
- Source :
- Genes and Diseases, Vol 10, Iss 6, Pp 2241-2244 (2023)
- Publication Year :
- 2023
- Publisher :
- KeAi Communications Co., Ltd., 2023.
- Subjects :
- Medicine (General)
R5-920
Genetics
QH426-470
Subjects
Details
- Language :
- English
- ISSN :
- 23523042
- Volume :
- 10
- Issue :
- 6
- Database :
- Directory of Open Access Journals
- Journal :
- Genes and Diseases
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.271e52bc9acb4f62b78b2386f780949e
- Document Type :
- article
- Full Text :
- https://doi.org/10.1016/j.gendis.2023.02.019